medical software development News
-
AVRA Medical Robotics Attends J.P. Morgan Healthcare Conference
ORLANDO, FL – January 17, 2020 – AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software; is attending the 38th J.P. Morgan ...
-
SIIM 2020: AI nearly halves breast ultrasound reading time
Using artificial intelligence (AI) to analyze breast ultrasound lesions reduced interpretation time by 49% at a healthcare center in Missouri. The software is particularly helpful for lesions classified as BI-RADS 2, 3, and 4A, attendees of the Society for Imaging Informatics in Medicine’s (SIIM) virtual meeting learned on June 24. For almost a year, the women’s imaging department at ...
-
Elucid Eyes Big Opportunity to Save Lives with Software Amidst Major Guideline Changes
BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, expects newly issued guidelines will be a catalyst for non-invasive image, revolutionizing the way patients with coronary artery disease are diagnosed and treated. In a highly anticipated document published online yesterday in Circulation and the Journal of ...
By Elucid
-
Flosonics Medical receives $500,000 in federal funding to accelerate the integration of FloPatch in hospitals across North America
The Government of Canada investment will help Flosonics Medical develop the IT infrastructure required for commercialization and create five new jobs in Greater Sudbury Flosonics Medical is pleased to announce that it has received a $500,000 investment from the Government of Canada to accelerate the integration of FloPatch in hospitals across North America. The repayable investment will help ...
-
Imorgon Medical to Install Ultrasound Enhancement System at Atlantic Medical Imaging
Imorgon Medical, a developer of wholly integrated software solutions that empower diagnostic ultrasound to deliver the highest quality of patient care, today announced that Atlantic Medical Imaging (AMI) plans to install the Imorgon Ultrasound Enhancement System. “We were searching for a technology solution that would improve ultrasound report communications by reducing radiologist report ...
-
Study Demonstrates Elucid’s Ability to Estimate RNA Expression from Non-Invasive Cardiovascular Imaging
Early detection of high risk plaque phenotypes holds the promise to prevent myocardial infarction and ischemic stroke by enabling personalized therapeutics BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, and researchers at the Karolinska Institutet (Stockholm, Sweden), led by Dr. Ulf Hedin, announced ...
By Elucid
-
Elucid Presents Results of the EVAPORATE Study at ESC Preventive Cardiology 2021 Late Breakers
BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced that first author and Elucid founder Andrew Buckler presented findings today from the EVAPORATE (Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking ...
By Elucid
-
Elucid Secures $8 Million in Series A Funding Led by MedTex Ventures and Global Health Impact Fund
BOSTON – Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today announced $8 Million in Series A financing led by MedTex Ventures and Global Health Impact Fund. New and existing investors Checkmate Capital, IAG Capital, BlueStone Venture Partners, University of Michigan – Wolverine Venture Fund, Willamette Valley Capital LLC, ...
By Elucid
-
Elucid Presents Data Demonstrating Its AI Software Can Uniquely Quantify Key Drivers of Heart Attack and Stroke from Computed Tomography
BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced today that its founder Andrew Buckler will present findings from two separate studies at the virtual Society of Cardiovascular Computed Tomography (SCCT) 16th Annual Scientific Meeting. The studies ...
By Elucid
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you